SCHEMBL9101734

SCHEMBL9101734

CC1=CC=C(C(N)=O)CC1(c1ccon1)c1cc2cnnc(-c3ccc(F)cc3Cl)c2n(C)c1=O

nearest known ligand 0.45

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 20/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9101728 0.74 MAPK14 (0.54) MAPK14
SCHEMBL9101724 0.70 MAPK14 (0.70) MAPK14
SCHEMBL1310952 0.69 MAPK14 (0.64) MAPK14
SCHEMBL1311180 0.65 MAPK14 (0.85) MAPK14
SCHEMBL1312747 0.65 MAPK14 (0.87) MAPK14
SCHEMBL1310925 0.65 MAPK14 (0.85) MAPK14
SCHEMBL1311772 0.62 MAPK14 (1.00) MAPK14
SCHEMBL9103827 0.62 MAPK14 (0.79) MAPK14
SCHEMBL1311301 0.61 MAPK14 (0.75) MAPK14
SCHEMBL1310635 0.60 MAPK14 (0.64) MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2334674-B1 Pyridazino- pyridinone compounds for the treatment of protein kinase mediated diseases. AMGEN INC (US) 2012-06-06 EP claimed